Cost is the biggest barrier to GLP-1 weight loss medications. Here's every pricing option in 2025.
US List Prices (No Insurance)
- Wegovy (2.4mg): ~$1,300-1,400/month
- Ozempic (off-label): ~$900-1,000/month
- Zepbound (15mg): ~$1,000-1,100/month
- Mounjaro (off-label): ~$1,000-1,100/month
- Saxenda: ~$1,300-1,400/month
With Insurance
~50-60% of large employer plans now cover at least one GLP-1 medication for weight management. Out-of-pocket costs with coverage: $0-$200/month depending on plan and formulary tier.
Manufacturer Savings
- Novo Nordisk (Wegovy): Savings cards → $0-25/month for eligible commercially insured patients
- Eli Lilly (Zepbound): LillyDirect caps at $550/month; $399/month self-pay vials at select pharmacies
Compounded GLP-1s
Available at $150-400/month from telehealth during the shortage period (2022-2024). As shortages resolve in 2025, FDA compounding restrictions tighten. Use only FDA-registered 503B facilities if considering compounded options.
International Prices
- UK NHS: Standard prescription charge (~£9.90) for eligible obesity patients
- Canada: ~CAD $300-350/month private
- Australia: ~AUD $400-500/month private
Apply This: Use our free Weight Loss Toolkit — TDEE, macros, 7-day meal plan and more. No sign-up needed.